Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Xenobiotica ; 39(5): 391-8, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19280383

RESUMEN

Salvinorin A is the main active psychoactive ingredient in Salvia divinorum, a Mexican plant that has been widely available as a hallucinogen in recent years. The aims of this study were to investigate the stability of salvinorin A in rat plasma, esterases responsible for its degradation, and estimation of the degradation products. The apparent first-order rate constants of salvinorin A at 37 degrees C, 25 degrees C, and 4 degrees C were 3.8 x 10(-1), 1.1 x 10(-1), and < 6.0 x 10(-3) h(-1), respectively. Salvinorin A degradation was markedly inhibited by the addition of sodium fluoride, an esterase inhibitor. Moreover, phenylmethylsulfonyl fluoride (serine esterase inhibitor) and bis-p-nitrophenylphosphate (carboxylesterase inhibitor) also inhibited salvinorin A degradation. In contrast, little or no suppression of the degradation was seen with 5,5'-dithiobis-2-nitrobenzoic acid (arylesterase inhibitor),ethopropazine (butyrylcholinesterase inhibitor), and BW284c51 (acetylcholineseterase inhibitor). These findings indicated that carboxylesterase was mainly involved in the salvinorin A hydrolysis in rat plasma.4. The degradation products of salvinorin A estimated by liquid chromatography-mass spectrometry included the deacetylated form (salvinorin B) and the lactone-ring-open forms of salvinorin A and salvinorin B. This lactone-ring-opening reactions were involved in calcium-dependent lactonase.


Asunto(s)
Diterpenos de Tipo Clerodano/farmacocinética , Diterpenos/farmacocinética , Esterasas/metabolismo , Alucinógenos/farmacocinética , Animales , Diterpenos/sangre , Diterpenos de Tipo Clerodano/sangre , Estabilidad de Medicamentos , Inhibidores Enzimáticos/farmacología , Esterasas/antagonistas & inhibidores , Alucinógenos/sangre , Masculino , Ratas , Ratas Wistar , Salvia/química
2.
Xenobiotica ; 38(12): 1476-86, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18982537

RESUMEN

1. The in vivo metabolism of alpha-methyltryptamine (AMT), a psychoactive tryptamine analogue, was studied in rats. 2. Male Wistar rats were administered 10 mg kg(-1) AMT orally and 24-h urine fractions were collected. After enzymatic hydrolysis of the urine sample, the metabolites were extracted by liquid-liquid extraction and analysed by gas chromatography/mass spectrometry (GC/MS). 3. 2-Oxo-AMT, 6-hydroxy-AMT, 7-hydroxy-AMT and 1'-hydroxy-AMT were detected as metabolites of AMT.


Asunto(s)
Triptaminas/orina , Animales , Cromatografía de Gases y Espectrometría de Masas , Masculino , Ratas , Ratas Wistar , Triptaminas/administración & dosificación , Triptaminas/metabolismo
3.
Xenobiotica ; 37(6): 679-92, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17614010

RESUMEN

The in vivo metabolism of 2,5-dimethoxy-4-propylthiophenethylamine (2C-T-7), a ring-substituted psychoactive phenethylamine, was studied in rat. Male Wistar rats were administered 10 mg/kg 2C-T-7 hydrochloride orally, and 24-h urine fractions were collected. After enzymatic hydrolysis of the urine sample, the metabolites were extracted by liquid-liquid extraction and analyzed by liquid chromatography/mass spectrometry. 2C-T-7-sulfoxide, N-acetyl-2C-T-7-sulfoxide, N-acetyl-2,5-dimethoxy-4-methylthiophenethylamine-sulfoxide, N-acetyl-2,5-dimethoxy-4-(2-hydroxypropylthio)phenethylamine-sulfoxide, and N-acetyl-2,5-dimethoxy-4-(2-hydroxypropylthio)phenethylamine-sulfone were detected as the primary metabolites of 2C-T-7. These findings suggest that sulfoxidation, sulfone formation, hydroxylation of the propyl side chain at the beta-position, and S-depropylation followed by methylation of thiol were the major metabolic pathways of 2C-T-7 in rat.


Asunto(s)
Fenetilaminas/farmacocinética , Psicotrópicos/farmacocinética , Animales , Cromatografía Liquida , Masculino , Espectrometría de Masas , Fenetilaminas/química , Fenetilaminas/orina , Psicotrópicos/química , Psicotrópicos/orina , Ratas , Ratas Wistar
4.
Nucleosides Nucleotides Nucleic Acids ; 19(10-12): 1993-2003, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11200286

RESUMEN

This paper deals with the synthesis of a new type of N-labeled peptidyl AMP, which would be used as a good substrate for analysis of the peptidyl transfer reaction on ribosome and for co-crystallization with ribosome. 4-(Dimethylamino)azobenzene-4'-sulfonyl (Dabsyl) was selected as the labeling group. (N-Dabsylglycyl)-L-leucyl AMP was synthesized from glycyl-L-leucine via a three-step procedure.


Asunto(s)
Adenosina Monofosfato/síntesis química , Péptidos/química , Adenosina Monofosfato/química , Análisis Espectral
5.
Pediatr Int ; 41(4): 363-8, 1999 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10453184

RESUMEN

BACKGROUND: The purpose of this study was to evaluate whether or not dopamine (DA) can penetrate to the central nervous system (CNS) from the blood in the infantile period in rats. METHODS: In a preliminary experiment, we administered a 50 mg/kg dose of DA hydrochloride, intraperitoneally, to 7-day-old rats (DA 50 mg/kg group), obtaining cerebrospinal fluid (CSF) both before and at 5, 10, 20, 30, 60 and 120 min after administration. The CSF levels of DA and its main metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), were then measured. Next, we investigated the DA transfer from blood to the CNS by administering doses of 1, 5, 10 and 30 mg/kg DA hydrochloride (DA 1, 5, 10 and 30 mg/kg groups). In these groups, CSF samples were obtained only at 10 and/or 60 min after DA administration, based on the results of the DA 50 mg/kg group. RESULTS: The DA concentrations in CSF significantly increased compared with values before DA administration in the DA 50 mg/kg group. The DA concentrations in the DA 30 mg/kg group, DOPAC concentrations in the DA 5, 10 and 30 mg/kg groups, and HVA concentrations in all groups were significantly higher than in the control (saline injection) group. CONCLUSIONS: These findings suggest easy DA transfer from blood to the CNS and immaturity of the blood-brain barrier for DA in the infantile period in rats.


Asunto(s)
Barrera Hematoencefálica , Sistema Nervioso Central/metabolismo , Dopamina/metabolismo , Animales , Animales Recién Nacidos , Dopamina/sangre , Dopamina/líquido cefalorraquídeo , Ratas , Ratas Wistar
6.
Nucleic Acids Res ; 24(19): 3700-6, 1996 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-8871547

RESUMEN

A small RNA derived from the decoding region of Escherichia coli 16S rRNA can bind to antibiotics of aminoglycosides (neomycin and paromomycin) that act on the small ribosomal subunit [Purohit,P. and Stern,S. (1994) Nature, 370, 659-662]. In the present study, the P-site subdomain was removed from this decoding region RNA to construct a 27mer RNA (designated as ASR-27), which includes the A-site-related region (positions 1402-1412 and 1488-1497) of 16S rRNA. Footprint experiments with dimethyl sulfate as a chemical probe indicated that the ASR-27 RNA can interact with the neomycin family in the same manner as the decoding region RNA. A mutagenesis analysis of the ASR-27 RNA revealed that paromomycin binding of ASR-27 involves the C1407.G1494 and C1409-G1491 base pairs, and the internal loop comprising A1408 and the nucleotides in positions 1492-1493, located between the two C.G base pairs. In addition, a G or U in position 1495, and base pairing between positions 1405 and 1496 are also involved. These structural features were found in a viral RNA element, the Rev-binding site of human immunodeficiency virus type-1, which may explain why neomycin can bind to this viral RNA.


Asunto(s)
Antibacterianos/metabolismo , ARN Bacteriano/metabolismo , ARN Ribosómico 16S/metabolismo , Aminoglicósidos , Productos del Gen rev/metabolismo , VIH-1/metabolismo , Mutagénesis , Unión Proteica , ARN Bacteriano/química , ARN Bacteriano/genética , ARN Ribosómico 16S/química , ARN Ribosómico 16S/genética , Productos del Gen rev del Virus de la Inmunodeficiencia Humana
7.
Infect Immun ; 63(3): 984-8, 1995 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-7868271

RESUMEN

The effect of an extracellular proteinase from the pathogenic yeast Candida albicans on the bactericidal and opsonizing activities of human serum was studied. The ability of human polymorphonuclear leukocytes to kill Staphylococcus aureus was greatly reduced when the bacteria were opsonized with human serum treated with the proteinase. The reduction in the opsonizing activity of human serum was attributed to degradation of the Fc portion of immunoglobulin G by the action of C. albicans proteinase as determined by immunoprecipitation reaction. However, the Fab portion of immunoglobulin G was resistant to proteolysis by the proteinase. A clear reduction in the bactericidal activity of human serum against Escherichia coli was observed when the serum was treated with C. albicans proteinase. The reduction of serum bactericidal activity was attributed to the degradation of complement C3 by proteolysis by the proteinase as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, while C5 resisted the action of the proteinase. As determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the proteinase also degrades endogenous proteinase inhibitors, such as alpha 2 macroglobulin and alpha 1 proteinase inhibitor, which are involved in regulating inflammation. These results suggest that destruction of a host's defense-oriented or regulatory proteins facilitates debilitation of the infected host.


Asunto(s)
Ácido Aspártico Endopeptidasas/farmacología , Actividad Bactericida de la Sangre/efectos de los fármacos , Candida albicans/inmunología , Proteínas Fúngicas/farmacología , Proteínas Opsoninas/efectos de los fármacos , Candida albicans/enzimología , Candida albicans/patogenicidad , Proteínas del Sistema Complemento/efectos de los fármacos , Proteínas del Sistema Complemento/metabolismo , Humanos , Inmunoglobulina G/efectos de los fármacos , Inmunoglobulina G/metabolismo , Proteínas Opsoninas/metabolismo , Inhibidores de Proteasas/metabolismo
8.
Clin Genet ; 33(4): 311-4, 1988 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-3359688

RESUMEN

A female infant with distal trisomy 17q is described. The anomaly resulted from a de novo inverted duplication of the 17q2405----q25.3 region as defined by high-resolution banding. The proband's overall clinical picture was in good agreement with those of previously reported cases of partial trisomy 17q. The phenotypic features relatively common to our and other reported cases, included mental and growth retardation, microcephaly, temporal retraction, blepharophimosis, saddle nose, thin upper lip, down-turned corner of the mouth, high-arched palate, low-set and deformed ears, webbed neck and lowered posterior hairline. A unique feature of the present case was systemic hirsutism.


Asunto(s)
Anomalías Múltiples/genética , Inversión Cromosómica , Cromosomas Humanos Par 17 , Discapacidad Intelectual/genética , Trisomía , Femenino , Humanos , Lactante , Cariotipificación , Fenotipo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...